
Cannasouth Investor Relations Material
Latest events

Investor Day 2023
Cannasouth
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cannasouth Limited
Access all reports
Cannasouth Limited is a biopharmaceutical company focused on the research, development, and commercialization of medicinal cannabis products. The company operates in areas such as cannabinoid extraction, formulation, and clinical research to create therapeutic products for various health conditions. Cannasouth also engages in cultivation and processing through joint ventures, aiming to ensure high-quality, sustainably produced raw materials for its products. The company is headquartered in Hamilton, New Zealand, and its shares are listed on the NZX.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CBD
Country
🇳🇿 New Zealand